Yeasts

SCYNEXIS Announces Two Oral Presentations on Pooled Data from the BREXAFEMME (Ibrexafungerp tablets) Phase 3 VANISH Program Demonstrating Consistent Efficacy in the Treatment for Vaginal Yeast Infections at the IDSOG 2021 Virtual Annual Meeting

Retrieved on: 
Thursday, July 29, 2021
Antifungals, Infectious diseases, Branches of biology, Pathogenic microbes, Yeasts, Medical specialties, Echinocandins, Candida auris, Cándida, 1,3-Beta-glucan synthase, Caspofungin

Ibrexafungerp [pronounced eye-BREX-ah-FUN-jerp] is an antifungal agent and the first representative of a novel class of structurally-distinct glucan synthase inhibitors, triterpenoids.

Key Points: 
  • Ibrexafungerp [pronounced eye-BREX-ah-FUN-jerp] is an antifungal agent and the first representative of a novel class of structurally-distinct glucan synthase inhibitors, triterpenoids.
  • This agent combines the well-established activity of glucan synthase inhibitors with the potential flexibility of having oral and intravenous (IV) formulations.
  • Ibrexafungerp is in late-stage development for multiple indications, including life-threatening fungal infections caused primarily by Candida (including C. auris) and Aspergillus species in hospitalized patients.
  • The New Drug Application (NDA) for BREXAFEMME (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021.

Europe Brewer's Spent Yeast Market Report 2021-2028 by Type (Liquid, Dry), & Application (Feed Supplement, Food Supplement) - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 29, 2021
Food, Beverage, Retail, Food and drink, Foods, Fermentation in food processing, Leavening agents, Food additives, Brewing, Yeasts, Baker's yeast, Brewer's spent grain, Beer, Glutamate flavoring, Amino acid

The "Europe Brewer's Spent Yeast Market Size, Share & Trends Analysis Report by Type (Liquid, Dry), by Application (Feed Supplement, Food Supplement), by Region and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Brewer's Spent Yeast Market Size, Share & Trends Analysis Report by Type (Liquid, Dry), by Application (Feed Supplement, Food Supplement), by Region and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The presence of numerous beer producers in Europe with large-scale production capacities has resulted in ample availability of brewer's by-products such as Brewer's Spent Yeast (BSY) and Brewer's Spent Grains (BSG).
  • The flavor-enhancing amino acids in spent yeast are also used in the food industry due to the presence of alanine, glycine, aspartic acid and glutamic acid.
  • The market is marked by the presence of companies that are vertically integrated to manufacture brewer's spent yeast as well as the subsequent food applications as feed and food supplements.

Angel Yeast Unveils New Purpose-Built Yeast and Biotechnology R&D Center

Retrieved on: 
Tuesday, July 13, 2021
Food and drink, Fermentation in food processing, Leavening agents, Yeasts, Fungi, Edible fungi, Food additives, Foods, Baker's yeast

YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.

Key Points: 
  • YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.
  • After it is put into operation, Angel Yeast estimates that over $60 million will be allocated annually into scientific research, with the aim to transform the complex into a leading global yeast technology research platform and a world-class biotechnology product R&D center.
  • We believe this project will further accelerate the advancement of Angel Yeast's innovation system in major industries, including yeast and yeast derivatives, healthy ingredients and raw materials, nutrition and healthcare, and non-yeast related biotechnologies," said Xiong Tao, chairman of Angel Yeast.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.

Angel Yeast Unveils New Purpose-Built Yeast and Biotechnology R&D Center

Retrieved on: 
Tuesday, July 13, 2021
Leavening agents, Food and drink, Fermentation in food processing, Yeasts, Edible fungi, Fungi, Foods, Baker's yeast, Breads, Robot Scientist

YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.

Key Points: 
  • YICHANG, China, July 13, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed high-tech yeast company in China, has officially opened the doors of its purpose-built complex for industry technology research and development.
  • Unveiled in June, the complex marks a major milestone for the group's scientific research process, as Angel Yeast continues to support the technological advancement of the biotechnology industry.
  • Since its inception, Angel Yeast has remained committed to scientific and technological progress, and is leading or participating in the formulation of all national and industry standards for yeast and yeast derivatives.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.

SCYNEXIS Announces Three Oral Presentations of Ibrexafungerp Demonstrating Clinical and In Vitro Activity Against Candida Species at the 31st ECCMID

Retrieved on: 
Monday, July 12, 2021
Antifungals, Branches of biology, Medical specialties, Infectious diseases, Yeasts, Pathogenic microbes, Echinocandins, Candida auris, Multiple drug resistance, Azole, Cándida, 1,3-Beta-glucan synthase

Ibrexafungerp [pronounced eye-BREX-ah-FUN-jerp] is an antifungal agent and the first representative of a novel class of structurally-distinct glucan synthase inhibitors, triterpenoids.

Key Points: 
  • Ibrexafungerp [pronounced eye-BREX-ah-FUN-jerp] is an antifungal agent and the first representative of a novel class of structurally-distinct glucan synthase inhibitors, triterpenoids.
  • This agent combines the well-established activity of glucan synthase inhibitors with the potential flexibility of having oral and intravenous (IV) formulations.
  • Ibrexafungerp is in late-stage development for multiple indications, including life-threatening fungal infections caused primarily by Candida (including C. auris) and Aspergillus species in hospitalized patients.
  • It has demonstrated broad-spectrum antifungal activity, in vitro and in vivo, against multidrug-resistant pathogens, including azole- and echinocandin-resistant strains.

Remedy, Australia's #1 Fermented Beverage Brand, Launches In The US

Retrieved on: 
Wednesday, June 23, 2021
Yeasts, Fermented foods, Organisms, Symbiosis, Baker's yeast, Fermentation in food processing, SCOBY, Food and drink, Biology

The result is a range of delicious canned drinks that can uniquely be stored in and out of the fridge.

Key Points: 
  • The result is a range of delicious canned drinks that can uniquely be stored in and out of the fridge.
  • Symbiotic Culture of Bacteria and Yeast) that is a descendant of the very first batch.
  • Remedy's mission has always been to shake up the drinks landscape for good by making it easier for people to make healthier choices.
  • No sugar means Remedy's healthy, strong cultures are able to stay alive throughout shelf life with no risk of refermentation.

UVC disinfection technology shown to inactivate Candida auris and Candida albicans

Retrieved on: 
Wednesday, June 16, 2021
Yeasts, Branches of biology, Pathogenic microbes, Medical specialties, Organisms, Gut flora, Cándida, Pathogenic fungus

MEMPHIS, Tenn., June 16, 2021 /PRNewswire/ --The Tru-D UVC disinfection device has been shown to be effective against Candida auris and Candida albicans in both direct and indirect line of sight, according to a new study, "Inactivation of Candida auris and Candida albicans by ultraviolet-C," in Infection Control and Hospital Epidemiology (ICHE).

Key Points: 
  • MEMPHIS, Tenn., June 16, 2021 /PRNewswire/ --The Tru-D UVC disinfection device has been shown to be effective against Candida auris and Candida albicans in both direct and indirect line of sight, according to a new study, "Inactivation of Candida auris and Candida albicans by ultraviolet-C," in Infection Control and Hospital Epidemiology (ICHE).
  • The device delivers a measured dose of UVC energy from a single location in the room, eliminating lingering pathogens in the space.
  • Candida auris is an emerging fungal pathogen that is often resistant to antifungal drugs.
  • Adding Tru-D's enhanced UVC disinfection technology to existing hospital cleaning protocols has been shown to provide a cleaner hospital environment for patients.

Worldwide Yeast Industry to 2026 - Featuring Angel Yeast, Cargill and DSM Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, June 11, 2021
Food, Beverage, Retail, Food and drink, Leavening agents, Fermentation in food processing, Yeasts, Fungi, Edible fungi, Organisms, Baker's yeast, Breads, Food

The "Yeast Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Yeast Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • Looking forward, the global yeast market is expected to grow at a CAGR of around 5% during the forecast period (2021-2026).
  • Yeast is a single-cell microorganism which can grow with or without oxygen.
  • Yeast is widely employed in the food and beverage (F&B) industry for preparing alcoholic beverages, bakery items and ready-to-eat (RTE) food products.

Less Salty, More Savory: Angel Yeast Reduces Global Sodium Intake with Yeast Extract Range

Retrieved on: 
Friday, June 11, 2021
Food and drink, Yeasts, Foods, Components, Food additives, Fermentation in food processing, Leavening agents, Breads, Nutritional yeast, Yeast extract, Baker's yeast, Yeast in winemaking

Among all the items on display, the yeast extract ("YE") solutions range garnered most attention.

Key Points: 
  • Among all the items on display, the yeast extract ("YE") solutions range garnered most attention.
  • With more than 20 years of R&D, Angel Yeast has played a leading role in popularizing a range of innovative YE solutions that enhance taste and help reduce sodium intake.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.
  • Its product range includes baker's yeast and ingredients, Chinese dim sum and seasoning, savory yeast extract, human health, animal nutrition, plant nutrition, distilled spirits and biofuels, microbial nutrition and enzymes.

Less Salty, More Savory: Angel Yeast Reduces Global Sodium Intake with Yeast Extract Range

Retrieved on: 
Friday, June 11, 2021
Food and drink, Food additives, Chemistry, Physical sciences, Fermentation in food processing, Leavening agents, Yeasts, Medicinal fungi, Baker's yeast, Sodium, Salt

Among all the items on display, the yeast extract ("YE") solutions range garnered most attention.

Key Points: 
  • Among all the items on display, the yeast extract ("YE") solutions range garnered most attention.
  • With more than 20 years of R&D, Angel Yeast has played a leading role in popularizing a range of innovative YE solutions that enhance taste and help reduce sodium intake.
  • In a bid to cut back sodium intake around the world, WHO Member States have agreed on a global target to drive down salt intake by 30 percent by 2025.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.